Session Type
Meeting
Search Results for thromboembolism
Abstract Number: 182
SHM Converge 2021
Background: Venous thromboembolism (VTE) poses a significant risk to patients in the hospital setting, and studies have shown that VTE prophylaxis should be incorporated into the management of high-risk patients during their hospital stay. However, many of these patients are still high-risk for VTE at the time of discharge and for up to three months […]
Abstract Number: 188
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Venous thromboembolism (VTE), both pulmonary embolism (PE) and deep vein thrombosis (DVT), causes morbidity and mortality in hospitalized patients. The duration of VTE risk in trauma, particularly after discharge, is not well understood, especially in the context of shortened hospital stays. Although guidelines provide recommendations for extended VTE prophylaxis after major orthopedic surgery, such […]
Abstract Number: 189
Hospital Medicine 2020, Virtual Competition
Background: Pediatric venous thromboembolism (VTE), although less common than in adults, is increasingly recognized as a significant and preventable cause of morbidity and mortality. There are no universal pediatric VTE guidelines, although the American College of Chest Physicians (ACCP) limits prophylaxis recommendations to a limited set of risk factors. Multiple centers have published institutional guidelines […]
Abstract Number: 201
SHM Converge 2023
Background: We evaluated whether a catheter-to-vein ratio (CVR) of >45% increases the risk of venous thromboembolism [VTE] and catheter occlusion associated with peripherally inserted central catheters (PICCs). Methods: From August 2020 to April 2022, trained abstractors collected demographic and clinical data on patients receiving PICCs while admitted at 52 hospitals participating in the Michigan Hospital […]
Abstract Number: 214
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Current national guidelines recommend using mechanical methods for venous thromboembolism (VTE) prophylaxis in hospitalized medical patients at elevated risk for thrombosis who have a contraindication to pharmacologic prophylaxis. Additionally, it is recommended to avoid the use of mechanical prophylaxis for patients who are at low risk for VTE. The Michigan Hospital Medicine Safety Consortium, […]
Abstract Number: 215
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: It is widely accepted that hospitalized patients warrant risk assessment for venous thromboembolism (VTE) upon hospital admission. Although many VTE risk assessment models include a patient mobility element for calculating risk, a standardized method of determining mobility is lacking. We sought to determine if physician assessment of anticipated patient mobility upon hospital admission using […]
Abstract Number: 225
Hospital Medicine 2020, Virtual Competition
Background: Guidelines suggest venous thromboembolism risk stratification, and against use of prophylaxis in low risk medically ill hospitalized patients. Our hospital did not have a formal risk stratification process embedded into the electronic medical record (EMR) for provider use, and therefore it was common practice to administer pharmacologic prophylaxis to most medically ill patients regardless […]
Abstract Number: 229
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Risk stratifying patients for potential development of hospital-related venous thromboembolism (VTE) is an important aspect of inpatient safety and is recommended by current guidelines. Many risk stratification tools are cumbersome and require significant time to complete. Developments have been made to partially or fully automate risk stratification tools, however there are restrictions within the […]
Abstract Number: 235
SHM Converge 2024
Background: Venous thromboembolism (VTE) is a leading cause of preventable in-hospital mortality and a primary focus of quality improvement/patient safety efforts. VTE prophylaxis reduces the incidence of in-hospital VTE, but nonadministration rates—primarily attributed to patient refusal—often reach 10-15%. Notably, nonadministration of VTE prophylaxis may correlate with higher incidence of hospital acquired VTE. Prior studies showed […]
Abstract Number: 247
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Venous thromboembolism (VTE) is a preventable and potentially fatal condition for which hospitalized medical patients are at risk. Compared with the more traditional option of unfractionated heparin, low molecular weight heparin (LMWH) has been shown to be superior for VTE prophylaxis with regard to both efficacy and bleeding risk, and to have a lower […]